Year-over-year earnings per share growth for the last twelve months: medicuspharma.com (MDCX)

medicuspharma.com - graphic logo of issuer MDCX

The GURU.Markets platform daily chart illustrates quarterly earnings per share dynamics, with the current level sitting around 79.50. The prospects for Medicus Pharma Ltd. (MDCX) are driven by successes in basal cell carcinoma therapy, regardless of the broader economy. Stable demand for dermatology guarantees resilience, although capitalization remains dependent on liquidity. Meanwhile, partners' production capacities are fully utilized, eliminating any downtime.

medicuspharma.com (MDCX) Year-over-year net earnings per share growth for the last 12 months: for the period 11/15/2024 - 11/15/2026

Comprehensive metric breakdowns and analytics for Medicus Pharma Ltd. (MDCX)

- share price and expert price forecast:
Stock Price Medicus Pharma Corp|MDCX - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value Medicus Pharma Ltd|MDCX - Business Value
- book capitalization data:
Net Assets per Single Share Medicus Pharma|MDCX - Company Net Assets|Market Capitalization to Book Value Ratio medicuspharma.com|MDCX - Company Assets
- debt and solvency information:
Total Debt to Capital Medicus Pharma Ltd.|MDCX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Medicus Pharma Ltd|MDCX - Company Total Debt Obligations|Debts to Book Capitalization Medicus Pharma Ltd.|MDCX - Company Long-Term Liabilities|Company Current Liabilities Medicus Pharma|Quick Liquidity medicuspharma.com
- earnings and market multiples details:
MDCX - Net Financial Result|Future Profit Medicus Pharma Ltd.|MDCX - Company Value to Net Income|Future Price to Earnings Medicus Pharma Limited|MDCX - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Medicus Pharma Ltd.|MDCX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Medicus Pharma|MDCX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months medicuspharma.com|MDCX - Earnings per share increase in current year|Net earnings per share growth forecast for next year Medicus Pharma Ltd.
- revenue and sales proceeds data:
MDCX - Company Sales|Projected Sales Volume Medicus Pharma Ltd|MDCX - P/S Multiple|Forward Price-to-Revenue Multiple Medicus Pharma Ltd.|MDCX - Revenue Dynamics YoY (Last Twelve Months)
Analysis of all company metrics:Medicus Pharma Corp - MDCX
Flagship merchandise of Medicus Pharma Corp

When constructing a long-term portfolio, it is critical to filter out market noise and focus on sustainable earnings per share (EPS) growth rates. This metric measures the percentage change in net income per quarter, which for the scalable business of Medicus Pharma Ltd. (MDCX) signifies the effective monetization of scientific research at low production costs, reflecting the real value dynamics of the asset through the quarterly EPS growth rate.

Main competitors

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel)|Year-over-year earnings per share growth for the last twelve months Oruka Pharma (ORKA)|Year-over-year net earnings per share change for the last twelve months Sanara MedTech|Quarterly EPS earnings growth DBVT (DBV Technologies SA)|Solesence Inc (SLSN) - Earnings per share growth in annualized terms for the last twelve months|DERM: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months FBRX (Forte Biosciences)|Empro Group (EMPG) - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year Sol-Gel Technologies Ltd. SLGL|Year-over-year net earnings per share growth for the last 12 months AXIL|Verrica Pharmaceuticals (VRCA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HOTH (Hoth Therapeutics, Inc.)|BFRI - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth VYNE (VYNE Therapeutics)|Year-over-year earnings per one share growth for the last 12 months SNOA|Quoin Pharmaceuticals Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Azitra Corporation AZTR|DRMA (Dermata) - Year-over-year net earnings per share growth for the last 12 months|Elevai Labs Inc. (ELAB) - Quarterly EPS earnings growth|RVNC (Revance Therapeutics, Inc.) - Quarterly EPS earnings growth